Venn Life Sciences and Encorium Group, Inc. Announce a Business Combination

DUBLIN & ESPOO, Finland--(BUSINESS WIRE)--Venn Life Sciences Holdings Limited (“Venn”), a leading provider of development consulting and resourcing services to the pharmaceutical, biotechnology and medical devices industries, and Encorium Group, Inc (“Encorium”), a full service CRO, today announced that they entered into an agreement for a business combination pursuant to which the Venn business and Encorium business will be combined into a new operation named Venn Life Sciences Limited, headquartered in Ireland. The combined business will have over 200 employees, operating from over 20 locations worldwide.

Back to news